JP2014525584A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014525584A5 JP2014525584A5 JP2014528663A JP2014528663A JP2014525584A5 JP 2014525584 A5 JP2014525584 A5 JP 2014525584A5 JP 2014528663 A JP2014528663 A JP 2014528663A JP 2014528663 A JP2014528663 A JP 2014528663A JP 2014525584 A5 JP2014525584 A5 JP 2014525584A5
- Authority
- JP
- Japan
- Prior art keywords
- c12orf56
- sample
- cancer
- dscr8
- sbk1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101000906689 Homo sapiens Uncharacterized protein C12orf56 Proteins 0.000 claims 16
- 102100023446 Uncharacterized protein C12orf56 Human genes 0.000 claims 16
- -1 COLl0A1 Proteins 0.000 claims 15
- 239000003795 chemical substances by application Substances 0.000 claims 12
- 108090000623 proteins and genes Proteins 0.000 claims 9
- 102100022142 Achaete-scute homolog 1 Human genes 0.000 claims 8
- 102100032484 Down syndrome critical region protein 8 Human genes 0.000 claims 8
- 101000901099 Homo sapiens Achaete-scute homolog 1 Proteins 0.000 claims 8
- 101001016533 Homo sapiens Down syndrome critical region protein 8 Proteins 0.000 claims 8
- 101000577881 Homo sapiens Macrophage metalloelastase Proteins 0.000 claims 8
- 101000990912 Homo sapiens Matrilysin Proteins 0.000 claims 8
- 101000814371 Homo sapiens Protein Wnt-10a Proteins 0.000 claims 8
- 101000693598 Homo sapiens Serine/threonine-protein kinase SBK1 Proteins 0.000 claims 8
- 102100027998 Macrophage metalloelastase Human genes 0.000 claims 8
- 102100030417 Matrilysin Human genes 0.000 claims 8
- 102100039461 Protein Wnt-10a Human genes 0.000 claims 8
- 102100025554 Serine/threonine-protein kinase SBK1 Human genes 0.000 claims 8
- 102100036217 Collagen alpha-1(X) chain Human genes 0.000 claims 7
- 101000875027 Homo sapiens Collagen alpha-1(X) chain Proteins 0.000 claims 7
- 101001120760 Homo sapiens Olfactomedin-4 Proteins 0.000 claims 7
- 101000577877 Homo sapiens Stromelysin-3 Proteins 0.000 claims 7
- 102100026071 Olfactomedin-4 Human genes 0.000 claims 7
- 108091006959 SLC35D3 Proteins 0.000 claims 7
- 102100032281 Solute carrier family 35 member D3 Human genes 0.000 claims 7
- 102100028847 Stromelysin-3 Human genes 0.000 claims 7
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims 6
- 102100025471 Epiphycan Human genes 0.000 claims 6
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims 6
- 101001056751 Homo sapiens Epiphycan Proteins 0.000 claims 6
- 102100035671 Cadherin EGF LAG seven-pass G-type receptor 3 Human genes 0.000 claims 5
- 102100035911 Guanine nucleotide-binding protein G(T) subunit gamma-T1 Human genes 0.000 claims 5
- 101000715671 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 3 Proteins 0.000 claims 5
- 101001073279 Homo sapiens Guanine nucleotide-binding protein G(T) subunit gamma-T1 Proteins 0.000 claims 5
- 101000854595 Homo sapiens Protein FAM166C Proteins 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 102100020939 Protein FAM166C Human genes 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 150000007523 nucleic acids Chemical group 0.000 claims 5
- 239000003550 marker Substances 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108020004414 DNA Proteins 0.000 claims 2
- 102000053602 DNA Human genes 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 2
- 239000010839 body fluid Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 108091058560 IL8 Proteins 0.000 claims 1
- 102000004890 Interleukin-8 Human genes 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161529500P | 2011-08-31 | 2011-08-31 | |
| US61/529,500 | 2011-08-31 | ||
| US201161542403P | 2011-10-03 | 2011-10-03 | |
| US61/542,403 | 2011-10-03 | ||
| PCT/US2012/053472 WO2013033609A2 (en) | 2011-08-31 | 2012-08-31 | Methods and compositions for the treatment and diagnosis of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014525584A JP2014525584A (ja) | 2014-09-29 |
| JP2014525584A5 true JP2014525584A5 (enExample) | 2015-10-29 |
Family
ID=47757190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014528663A Pending JP2014525584A (ja) | 2011-08-31 | 2012-08-31 | 癌の治療および診断のための方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140206574A1 (enExample) |
| EP (1) | EP2751570A4 (enExample) |
| JP (1) | JP2014525584A (enExample) |
| KR (1) | KR20140057361A (enExample) |
| CN (1) | CN103890587A (enExample) |
| AU (1) | AU2012301664A1 (enExample) |
| CA (1) | CA2844793A1 (enExample) |
| HK (1) | HK1199099A1 (enExample) |
| WO (1) | WO2013033609A2 (enExample) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0913578A2 (pt) | 2008-05-14 | 2017-06-06 | Dermtech Int | diagnose de melanoma e lentigo solar por análise de ácido nucléico |
| WO2014055398A1 (en) | 2012-10-05 | 2014-04-10 | Siemens Healthcare Diagnostics Inc. | Method for detecting an increased risk or incidence of colorectal cancer |
| EP2853596A1 (en) * | 2013-09-30 | 2015-04-01 | IKBT (Institut für Klinische Biomedizinische Forschung Thurgau) | Protein phosphatase inhibitor |
| GB201320061D0 (en) * | 2013-11-13 | 2013-12-25 | Electrophoretics Ltd | Materials nad methods for diagnosis and prognosis of liver cancer |
| EP2876442A1 (en) * | 2013-11-22 | 2015-05-27 | Institut de Cancérologie de l'Ouest | Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast cancer |
| CN106796236A (zh) * | 2013-12-30 | 2017-05-31 | 促进军事医学的亨利·M·杰克逊基金会公司 | 前列腺癌基因谱和使用所述基因谱的方法 |
| US11578373B2 (en) | 2019-03-26 | 2023-02-14 | Dermtech, Inc. | Gene classifiers and uses thereof in skin cancers |
| WO2016179043A1 (en) | 2015-05-01 | 2016-11-10 | Dermtech, Inc. | Non-invasive skin collection system |
| US11060149B2 (en) * | 2014-06-18 | 2021-07-13 | Clear Gene, Inc. | Methods, compositions, and devices for rapid analysis of biological markers |
| KR101779147B1 (ko) * | 2014-07-04 | 2017-09-20 | 연세대학교 산학협력단 | Kiaa1199를 이용한 췌장암의 진단 또는 치료용 조성물 |
| CN105675735B (zh) * | 2014-11-19 | 2018-07-17 | 上海市第六人民医院 | 乳腺癌诊断标记物组合、应用及其测定方法 |
| JP6551967B2 (ja) * | 2015-01-30 | 2019-07-31 | 国立大学法人山口大学 | 肝細胞がんの転移性再発リスクの予測方法 |
| JP6803572B2 (ja) * | 2015-03-06 | 2020-12-23 | 国立大学法人東海国立大学機構 | Ｓｙｔ１３、ｓｙｔ８、ａｎｏｓ１発現量による胃癌腹膜播種の検査方法、検査キット、分子標的治療薬スクリーニング方法、及び治療薬 |
| GB201504502D0 (en) * | 2015-03-17 | 2015-04-29 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| TWI755157B (zh) | 2015-03-17 | 2022-02-11 | 德商英麥提克生物技術股份有限公司 | 用於抗胰臟癌與其他癌症的免疫治療的新穎胜肽及胜肽的組合 |
| JP2016214239A (ja) * | 2015-05-15 | 2016-12-22 | 国立大学法人高知大学 | 膵がんマーカー |
| JP6659250B2 (ja) * | 2015-06-19 | 2020-03-04 | 国立大学法人滋賀医科大学 | 癌の検査方法、癌細胞増殖阻害剤、抗癌剤及び抗癌剤のスクリーニング方法 |
| CN105463070B (zh) * | 2015-07-08 | 2018-12-28 | 上海市同仁医院 | Uca1基因在制备诊断结直肠癌产品中的应用 |
| US10370647B2 (en) * | 2015-07-22 | 2019-08-06 | National University Corporation Tottori University | Host regulatory factor that enhances replication and/or propagation of vaccinia virus |
| WO2017018735A1 (ko) * | 2015-07-24 | 2017-02-02 | 고려대학교 산학협력단 | 노화 판별용, 비만 판별용, 암 진단용 바이오마커 및 이를 이용한 진단키트 |
| US20170089905A1 (en) | 2015-09-28 | 2017-03-30 | Abbott Japan Co., Ltd. | Methods of diagnosing hepatocellular carcinoma and pancreatic cancer |
| EP3383418B1 (en) * | 2015-12-04 | 2021-10-20 | Board of Regents, The University of Texas System | Slc45a2 peptides for immunotherapy |
| WO2017113565A1 (zh) * | 2015-12-29 | 2017-07-06 | 中国医学科学院肿瘤医院 | 基于蛋白标志物psg3辅助诊断肝癌或消化道癌症患者的试剂盒 |
| CN105504060B (zh) * | 2015-12-31 | 2018-10-26 | 陆梅生 | 一种抗胃癌细胞表面功能性表达的足萼样蛋白前体亚型2的单克隆抗体及其制备方法和用途 |
| US10294297B2 (en) | 2016-01-29 | 2019-05-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treatment using anti-NMU agents |
| CN106399306B (zh) * | 2016-04-12 | 2019-11-05 | 西安交通大学第一附属医院 | 靶向人lncRNA-UCA1抑制膀胱癌的sgRNA、基因载体及其应用 |
| SE540173C2 (en) | 2016-04-20 | 2018-04-24 | Hiloprobe Ab | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor |
| CN106047874B (zh) * | 2016-06-02 | 2019-01-18 | 吉林大学 | 一种靶向sall4基因的脱氧核酶分子及在乳腺癌基因治疗中的应用 |
| EP3468546A4 (en) | 2016-06-09 | 2020-04-01 | Cedars-Sinai Medical Center | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER |
| CN108329387B (zh) * | 2017-01-17 | 2021-07-27 | 复旦大学附属肿瘤医院 | 癌症相关的肿瘤特异转录本lin28b-tst及其用途 |
| TWI782020B (zh) * | 2017-05-16 | 2022-11-01 | 香港中文大學 | 整合單細胞及血漿游離rna分析 |
| WO2018218737A1 (zh) * | 2017-06-01 | 2018-12-06 | 立森印迹诊断技术（无锡）有限公司 | 一种印记基因在膀胱肿瘤中的分级模型及其组成的系统 |
| CN107312096B (zh) * | 2017-07-17 | 2019-12-20 | 湖北大学 | 用于检测组蛋白位点三甲基化修饰的重组蛋白及其应用 |
| CN107449916B (zh) * | 2017-07-27 | 2019-05-21 | 北京邦菲生物科技有限公司 | 肺癌和肺部结节蛋白特征谱及其构建方法与应用 |
| CN107807243B (zh) * | 2017-11-24 | 2020-08-07 | 暨南大学 | 一种食管癌的生物标志物及其应用 |
| CN108152496B (zh) * | 2017-11-24 | 2020-10-27 | 暨南大学 | Mest蛋白在制备肺癌辅助诊断和/或预后判断的试剂盒中的应用 |
| KR102673699B1 (ko) * | 2017-12-13 | 2024-06-17 | 이노비오 파마수티컬즈, 인크. | Lemd1을 표적화하는 암 백신 및 이의 용도 |
| US11976332B2 (en) | 2018-02-14 | 2024-05-07 | Dermtech, Inc. | Gene classifiers and uses thereof in non-melanoma skin cancers |
| GB201803750D0 (en) * | 2018-03-08 | 2018-04-25 | Immunocore Ltd | Method |
| CN112639132A (zh) * | 2018-05-29 | 2021-04-09 | 图尔库大学 | L1td1作为结肠癌的预测生物标志物 |
| CN108796079B (zh) * | 2018-06-06 | 2021-07-27 | 天津医科大学肿瘤医院 | 一种逆转录转座基因l1-fggy及其作为肺鳞癌标志物的用途 |
| CN109116023B (zh) * | 2018-06-14 | 2021-06-04 | 郑州大学第一附属医院 | 一种肺癌标志物抗-mmp12自身抗体及其应用 |
| WO2019241899A1 (es) * | 2018-06-20 | 2019-12-26 | Pontificia Universidad Catolica De Chile | Detección no invasiva de cáncer gástrico a través de la detección en sangre de la metilación de reprimo like |
| US20210275596A1 (en) * | 2018-07-20 | 2021-09-09 | Cell2In, Inc. | Application of gene profile for cells isolated using fresh-tracer |
| CN109082473A (zh) * | 2018-10-16 | 2018-12-25 | 兰州大学 | 一种公牛znf280ay基因拷贝数变异的检测方法及应用 |
| WO2020080861A1 (ko) | 2018-10-19 | 2020-04-23 | 한국생명공학연구원 | Syt11 억제제를 유효성분으로 포함하는 위암 치료용 조성물 |
| JP7216995B2 (ja) * | 2018-12-05 | 2023-02-02 | 学校法人関西医科大学 | 胸腺癌バイオマーカー及び胸腺腫瘍の予後予測マーカー |
| CN109371023A (zh) * | 2018-12-11 | 2019-02-22 | 宁夏医科大学总医院 | 一种环状RNA hsa_circKIAA1199_006及其特异性扩增引物和应用 |
| US12134655B2 (en) | 2019-04-30 | 2024-11-05 | Absci Corporation | Cancer associated antibody compositions and methods of use |
| CN110218796B (zh) * | 2019-06-27 | 2020-01-17 | 江门市中心医院 | 用于乳腺癌骨转移诊疗的新靶标pcdhb2 |
| CN112147324A (zh) * | 2019-06-28 | 2020-12-29 | 欧蒙医学实验诊断股份公司 | 自身抗体的检测 |
| WO2021003246A1 (en) * | 2019-07-01 | 2021-01-07 | Accure Health Inc. | Predictive liquid markers for cancer immunotherapy |
| CN110796625B (zh) * | 2019-10-30 | 2023-06-20 | 重庆邮电大学 | 一种基于组稀疏表示和加权全变分的图像压缩感知重构方法 |
| CN111218509B (zh) * | 2019-12-23 | 2023-07-04 | 西南医科大学附属医院 | 乳腺癌的新诊断标志物ppef1及其应用 |
| WO2021231327A2 (en) * | 2020-05-12 | 2021-11-18 | Memorial Sloan Kettering Cancer Center | Methods for de-cloaking cancer from the immune system through downregulation of cancer-produced pregnancy specific glycoprotein |
| CN115851942A (zh) * | 2020-12-22 | 2023-03-28 | 上海市第一人民医院 | 诊断标志物gata4在胰腺“炎癌转化”中的应用 |
| CN115216542A (zh) * | 2021-04-15 | 2022-10-21 | 复旦大学附属华山医院 | 一组肿瘤筛查、鉴别的标志物及应用 |
| CN116087519B (zh) * | 2021-05-17 | 2025-03-14 | 郑州大学第一附属医院 | 一种用于高危人群贲门腺癌早期筛查的标志物及其应用 |
| CN113504370B (zh) * | 2021-06-29 | 2024-02-09 | 广州金研生物医药研究院有限公司 | Mapk15蛋白在前列腺癌的恶性程度或预后程度预测中的应用 |
| CN115537464B (zh) * | 2021-06-30 | 2023-06-20 | 武汉艾米森生命科技有限公司 | 一种结直肠癌或癌前病变的诊断或辅助诊断试剂、核酸组合、试剂盒及应用 |
| CN113980963B (zh) * | 2021-09-03 | 2024-05-28 | 中山大学 | 一种寡核苷酸rna双链分子及其在制备治疗恶性肿瘤药物中的应用 |
| CN114807369A (zh) * | 2021-11-15 | 2022-07-29 | 四川大学华西医院 | 一种与前列腺癌显著相关的潜在抗原、免疫分型及其构建方法和应用 |
| CN115992229B (zh) * | 2022-07-22 | 2023-07-07 | 中南大学湘雅三医院 | 一种胰腺癌预后风险评估的lncRNA标记物、模型及其应用 |
| CN117486999B (zh) * | 2022-08-30 | 2025-03-18 | 暨南大学 | 一种肿瘤T细胞抗原表位肽、pMHC及其制备和应用 |
| CN115838804A (zh) * | 2022-10-07 | 2023-03-24 | 厦门医学院 | 血浆外泌体lncRNAs作为靶标在急性髓系白血病诊断和疗效监测中的应用 |
| CN115786518A (zh) * | 2022-11-29 | 2023-03-14 | 广东医科大学附属医院 | 嗅素结构域家族蛋白4（olfm4）在结肠癌检测产品中的应用 |
| CN116482365B (zh) * | 2023-03-14 | 2023-10-20 | 南京芯原生物科技有限公司 | 用于检测血清抗体的蛋白组合物及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0114786A (pt) * | 2000-10-18 | 2003-08-12 | Glaxosmithkline Biolog Sa | Composição imunogênica, método de tratamento de um paciente que sofre de, ou que é suscetìvel a, um câncer, e, uso de uma combinação de uma saponina, um oligotìdeo imunoestimulador e um antìgeno de câncer, e, método para a manufatura de uma composição |
| AU2002322280A1 (en) * | 2001-06-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| WO2003057916A2 (en) * | 2002-01-09 | 2003-07-17 | Riken | Cancer profiles |
| US20060188889A1 (en) * | 2003-11-04 | 2006-08-24 | Christopher Burgess | Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| DK1641810T4 (en) * | 2003-06-24 | 2017-07-03 | Genomic Health Inc | Predicting the likelihood of cancer recurrence |
| US20050208499A1 (en) * | 2004-02-04 | 2005-09-22 | Graff Jonathan M | Markers for diagnosing and treating breast and ovarian cancer |
| ES2339132T7 (es) * | 2004-08-10 | 2012-03-16 | Cardiff Biologicasl Limited | Metodos y kit para el pronostico de cancer de mama. |
| ATE493515T1 (de) * | 2005-06-08 | 2011-01-15 | Hitachi Chemical Res Ct Inc | Verfahren zur vorhersage der immunreaktion auf neoplastische krankheiten auf der grundlage des mrna-ausdrucksprofil in neoplastischen zellen und stimulierten leukozyten |
| US20070218512A1 (en) * | 2006-02-28 | 2007-09-20 | Alex Strongin | Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management |
| DE102006024416A1 (de) * | 2006-05-24 | 2008-04-30 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Prädiktives Genexpressionsmuster für kolorektale Karzinome |
| JP5564249B2 (ja) * | 2006-06-23 | 2014-07-30 | アレシア・バイオセラピューティクス・インコーポレーテッド | 癌に関与するポリヌクレオチド配列およびポリペプチド配列 |
| RU2473555C2 (ru) * | 2006-12-19 | 2013-01-27 | ДжинГоу, Инк. | Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных |
| AT504702A1 (de) * | 2006-12-22 | 2008-07-15 | Arc Austrian Res Centers Gmbh | Set von tumormarkern |
| WO2008089577A1 (en) * | 2007-01-26 | 2008-07-31 | Vm Institute Of Resaerch | Breast cancer gene array |
| EP2048242A1 (de) * | 2007-10-08 | 2009-04-15 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Microarray für die Expressionsanalyse der zellulären Glykosylierungsmaschinerie |
| EP2215258A4 (en) * | 2007-10-23 | 2010-12-01 | Clinical Genomics Pty Ltd | METHOD FOR DIAGNOSING TUMOR DISEASES |
| US20110065605A1 (en) * | 2008-05-14 | 2011-03-17 | Eth Zurich | Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith |
| WO2009142257A1 (ja) * | 2008-05-21 | 2009-11-26 | 東レ株式会社 | 食道ガン判定用組成物及び方法 |
| ES2469802T3 (es) * | 2008-10-20 | 2014-06-20 | Valipharma | Métodos y usos que implican aberraciones genéticas de NAV 3 y expresión aberrante de múltiples genes |
| US8541170B2 (en) * | 2008-11-17 | 2013-09-24 | Veracyte, Inc. | Methods and compositions of molecular profiling for disease diagnostics |
| CN102348979A (zh) * | 2009-03-09 | 2012-02-08 | 乔治亚大学研究基金公司 | 胃癌诊断用蛋白标记的鉴定 |
| JP2013501792A (ja) * | 2009-08-10 | 2013-01-17 | サミュメッド リミテッド ライアビリティ カンパニー | Ｗｎｔ／ｂ−カテニンシグナル伝達経路阻害剤としてのインダゾールおよびその治療的使用 |
| CA2787657A1 (en) * | 2010-02-23 | 2011-09-01 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
-
2012
- 2012-08-31 WO PCT/US2012/053472 patent/WO2013033609A2/en not_active Ceased
- 2012-08-31 CN CN201280051957.8A patent/CN103890587A/zh active Pending
- 2012-08-31 HK HK14112558.3A patent/HK1199099A1/xx unknown
- 2012-08-31 CA CA2844793A patent/CA2844793A1/en not_active Abandoned
- 2012-08-31 JP JP2014528663A patent/JP2014525584A/ja active Pending
- 2012-08-31 AU AU2012301664A patent/AU2012301664A1/en not_active Abandoned
- 2012-08-31 US US14/240,698 patent/US20140206574A1/en not_active Abandoned
- 2012-08-31 KR KR1020147008058A patent/KR20140057361A/ko not_active Withdrawn
- 2012-08-31 EP EP12827944.5A patent/EP2751570A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014525584A5 (enExample) | ||
| Hoseok et al. | Lung cancer biomarkers | |
| Wang et al. | Label-free isolation and mRNA detection of circulating tumor cells from patients with metastatic lung cancer for disease diagnosis and monitoring therapeutic efficacy | |
| Labib et al. | Aptamer and antisense-mediated two-dimensional isolation of specific cancer cell subpopulations | |
| Hizir et al. | Simultaneous detection of circulating oncomiRs from body fluids for prostate cancer staging using nanographene oxide | |
| Park et al. | Fully automated circulating tumor cell isolation platform with large-volume capacity based on lab-on-a-disc | |
| WO2013033629A3 (en) | Methods and compositions for the treatment and diagnosis of colorectal cancer | |
| CN113286883A (zh) | 使用rna分析以检测疾病的方法 | |
| JP2014144959A5 (enExample) | ||
| JP2008249727A5 (enExample) | ||
| Zhong et al. | Discovery and validation of extracellular vesicle‐associated miRNAs as noninvasive detection biomarkers for early‐stage non‐small‐cell lung cancer | |
| JP2014508298A5 (enExample) | ||
| Yee et al. | Extracellular vesicles as potential biomarkers for early detection and diagnosis of pancreatic cancer | |
| JP2011229532A5 (enExample) | ||
| CN110205378B (zh) | 一组脊柱结核血浆miRNA联合诊断标记物及其应用 | |
| US9429575B2 (en) | DNA aptamer specifically binding to EN2 (engrailed-2) and use thereof | |
| Santos et al. | Liquid biopsy: The value of different bodily fluids | |
| JP2014533372A5 (enExample) | ||
| JP2013505007A5 (enExample) | ||
| Mostufa et al. | Giant magnetoresistance based biosensors for cancer screening and detection | |
| JP2014221834A5 (enExample) | ||
| JP2016536568A5 (enExample) | ||
| US20150204882A1 (en) | Methionine metabolites predict aggressive cancer progression | |
| Bertok et al. | Novel prostate cancer biomarkers: Aetiology, clinical performance and sensing applications | |
| CN107586839A (zh) | 循环肿瘤细胞多种标志物联合检测试剂盒及其应用 |